Jalota Deepika 4
4 · PMV Pharmaceuticals, Inc. · Filed Sep 18, 2023
Insider Transaction Report
Form 4
Jalota Deepika
Chief Development Officer
Transactions
- Sale
Common Stock
2023-09-15$6.62/sh−4,104$27,168→ 29,946 total
Footnotes (1)
- [F1]The reported shares were sold to cover the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.